Brief: Tivic Health Reports White House Briefing And FDA Meetings Secured Positive Interest In Potential Military And Defense Applications Of Its Product Candidates
22/04/2025 13:35
April 22 (Reuters) - Tivic Health Systems Inc TIVC.O: TIVIC HEALTH REPORTS WHITE HOUSE BRIEFING AND FDA MEETINGS SECURED POSITIVE INTEREST IN POTENTIAL MILITARY AND DEFENSE APPLICATIONS OF ITS PRODUCT CANDIDATES Source text: ID:nBw3kB0xJa Further company coverage: TIVC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Valion Bio
See all newsBrief: Valion Bio Reports First Quarter 2026 Financial Results
Navigate FDA Submission
Brief: Tivic Health Systems Inc To Rebrand As Valion Bio, Ticker To Vbio Effective April 28, 2026
Brief: Tivic Health Systems Inc - Appoints Michael K. Handley As CEO And Board Member Effective March 3, 2026 - SEC Filing
Brief: Tivic Health Systems Enters Stock Purchase Agreement With Tumim Stone Capital